SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. Present Data at the 72nd Boehringer Ingelheim Pharmaceuticals, Inc. Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine